Eczema

Introduction

Eczema, also known as atopic dermatitis, is a chronic, relapsing inflammatory skin disorder characterized by dry, itchy, and inflamed patches. Globally, it affects a significant proportion of the population, with prevalence varying by age and region. Studies within the Gulf Cooperation Council (GCC) countries indicate a notable burden of the condition. For instance, a study in Dubai, UAE, indicated a prevalence of 4-5%. Studies in Saudi Arabia have shown varying prevalence rates, with one study of children aged 6-12 years reporting 14% physician-diagnosed atopic dermatitis. These figures highlight the substantial impact of eczema on individuals and healthcare systems within the GCC. The region’s unique environmental challenges, including an arid climate, frequent sandstorms, intense UV exposure, and the widespread use of air conditioning, alongside cultural practices, necessitate a tailored approach to eczema management.

What Is Eczema?

Eczema arises from a complex interplay of skin barrier dysfunction and immune dysregulation.

Barrier Defect: Genetic factors, particularly mutations in the filaggrin (FLG) gene, lead to a reduction in key structural proteins within the skin’s outer layer (epidermis). This compromised barrier function results in increased transepidermal water loss (TEWL) and enhanced penetration of irritants and allergens. In the dry GCC climate and with the lipid-stripping effects of sweat and air conditioning, this barrier defect is often exacerbated.

Immune Response: The penetration of allergens triggers an abnormal immune response, predominantly involving the Th2 pathway. This leads to the release of pro-inflammatory cytokines such as interleukin-4 (IL-4) and interleukin-13 (IL-13), which further impair skin barrier function by downregulating proteins like filaggrin and loricrin, and perpetuate the cycle of inflammation and itching.

Types of Eczema

  • Atopic Dermatitis: The most common type, often beginning in childhood and frequently associated with a personal or family history of allergic conditions such as asthma and allergic rhinitis.
  • Contact Dermatitis: Results from direct skin contact with irritants (e.g., harsh soaps, detergents, fragrances) or allergens (e.g., nickel, latex, para-phenylenediamine (PPD) found in some henna).
  • Dyshidrotic Eczema: Characterized by the sudden onset of small, intensely itchy blisters (vesicles) on the palms, soles, and sides of the fingers and toes, often worsened by heat, sweating, and stress.
  • Seborrheic Dermatitis: Affects sebum-rich areas such as the scalp, face (eyebrows, nasolabial folds), and upper chest. In infants, it is commonly known as “cradle cap.” The Malassezia yeast is thought to play a role. It can be more prevalent in humid climates.
  • Nummular Eczema: Presents as coin-shaped, itchy patches (plaques) on the limbs and trunk. Its exact cause is unknown but can be triggered by dry skin or insect bites.
  • Stasis Dermatitis: Occurs on the lower legs in individuals with poor circulation (venous insufficiency), leading to inflammation, swelling, and skin changes.

Causes and Risk Factors

  • Genetic Predisposition: A strong family history of eczema, asthma, or allergic rhinitis significantly increases the risk. Studies within the GCC highlight the role of genetic factors in the development of eczema.
  • Climate and Environment: The GCC’s harsh environment, with recurrent sandstorms, high UV radiation, and the dehydrating effects of indoor air conditioning, can severely impact the skin barrier.
  • Cultural Practices: Traditional practices such as the frequent use of perfumed oils and the wearing of synthetic fabrics like polyester in abayas and thobes can act as irritants. Traditional henna application may also be a trigger due to the presence of PPD in some formulations. Hot water washing can further strip the skin of its natural oils.
  • Immune Hyperreactivity: An overactive Th2 immune response leads to an exaggerated reaction to common environmental allergens such as dust mites, pollen, and microbial antigens.

Symptoms of Eczema

  • Itching (pruritus): The most defining and often the most distressing symptom. Itching may be constant or triggered by heat, sweat, or irritation.
  • Redness and inflammation: Affected areas appear red and swollen during active flares.
  • Dryness and scaling: The skin often becomes rough, flaky, or cracked, especially in chronic eczema.
  • Blisters or oozing (in acute stages): Some cases may involve fluid-filled bumps that leak and form crusts.
  • Crusting and thickening: Long-term scratching can lead to a leathery texture known as lichenification.
  • Pain or burning: In cases with skin cracks (fissures) or secondary infection.

Eczema can present in three main stages:

  • Acute Eczema: Characterized by sudden onset of intense itching, redness, and small, fluid-filled blisters that may ooze and crust.
  • Subacute Eczema: A transition stage with drier, scaly, and less intensely red skin. Itching persists but may be milder.
  • Chronic Eczema: Results from long-term inflammation and scratching, leading to thickened, leathery skin (lichenification), persistent itch, and potential skin cracks.

Potential Complications

  • Secondary Skin Infections: The compromised skin barrier increases susceptibility to bacterial infections, commonly caused by Staphylococcus aureus, and viral infections, such as eczema herpeticum caused by the herpes simplex virus. These infections can manifest as weeping, crusting, pustules, or rapidly spreading painful blisters.
  • Chronic Itch-Scratch Cycle: Persistent itching (pruritus) leads to scratching, which further damages the skin barrier, causing more inflammation and intensifying the itch, creating a vicious cycle.
  • Sleep Disruption: Nocturnal pruritus is a hallmark of eczema, leading to significant sleep loss, fatigue, and impaired cognitive function, particularly in children.
  • Psychological Burden: The visible nature of eczema lesions, along with chronic discomfort and sleep deprivation, can contribute to anxiety, depression, social withdrawal, and a diminished quality of life.

Diagnosis of Eczema

  • Clinical Evaluation: Diagnosis is primarily based on a thorough physical examination of the skin, the characteristic pattern and distribution of the rash, the chronicity of symptoms, and a detailed personal and family history of atopy (eczema, asthma, allergic rhinitis).
  • Patch Testing: This may be performed, particularly in cases of suspected contact dermatitis, to identify specific allergenic triggers.
  • Dermoscopy: A non-invasive skin surface microscopy technique that can aid in differentiating eczema from other skin conditions like psoriasis or fungal infections by revealing characteristic vascular and scale patterns.

Treatment of Eczema

Management strategies for eczema aim to alleviate itching and inflammation, repair the skin barrier, and prevent future flares:

  • Emollients: Regular and liberal use of emollients is the cornerstone of eczema management. Products containing ceramides (e.g., Metabase Cream) help to replenish lost skin lipids, while occlusives like dimethicone and petrolatum help to seal in moisture and protect against environmental irritants.
  • Topical Corticosteroids (TCS): Prescription creams and ointments of varying potencies are used to reduce inflammation and itching during flare-ups. They should be used as directed by a healthcare professional, typically for short periods or on an intermittent basis. Low-potency TCS (e.g., hydrocortisone) may be used for milder flares or on more sensitive areas.
  • Topical Calcineurin Inhibitors (TCIs): Tacrolimus and pimecrolimus are non-steroidal anti-inflammatory creams and ointments that can be used for flares, particularly on the face and skin folds, where TCS use may be limited due to potential side effects.
  • Antihistamines: Non-sedating antihistamines (e.g., cetirizine, loratadine) may help to reduce daytime itching, although their direct anti-inflammatory effects are limited. Sedating antihistamines (e.g., hydroxyzine) can be useful at night to improve sleep quality, especially when itching is severe.
  • Phototherapy: Narrowband ultraviolet B (UVB) phototherapy, administered in specialized dermatology centers, can be an effective treatment for moderate to severe eczema in older children and adults.
  • Systemic Immunosuppressants: In severe, refractory cases, oral medications such as corticosteroids, cyclosporine, azathioprine, or methotrexate may be prescribed by a dermatologist for short-term or longer-term management.
  • Biologics: Dupilumab is an injectable biologic medication that targets specific inflammatory pathways (IL-4 and IL-13 signaling) involved in atopic dermatitis. It is approved for moderate to severe eczema in adults and some adolescents whose condition is not adequately controlled with topical treatments.

How Metabase Cream Helps

Metabase Cream’s carefully balanced formula supports eczema-prone skin in five key ways:

  • Barrier Restoration: Ceramides replenish the lipids in the stratum corneum, repairing and strengthening the skin’s natural barrier to prevent further moisture loss.
  • Intensive Hydration: Urea, a powerful humectant, draws water from deeper skin layers into the epidermis, boosting hydration and reducing roughness.
  • Moisture Sealing: Dimethicone forms an occlusive film on the skin’s surface, effectively locking in moisture and shielding against irritants and allergens.
  • Soothing & Calming: Panthenol (pro-vitamin B₅) and Calendula extract work synergistically to reduce redness, itch, and inflammation, providing immediate relief during flare-ups.
  • Skin Renewal: Allantoin promotes gentle exfoliation of dead skin cells and supports cell turnover, smoothing rough patches and helping the skin heal more efficiently.
  • Enhanced Elasticity & Comfort: The blend of humectants (like urea) and emollients (ceramides, dimethicone) helps restore skin flexibility, so it feels softer and less prone to cracking.

When to See a Doctor

It is important to consult a dermatologist if:

  • The rash covers more than 30% of the body surface area.
  • There are signs of skin infection, such as fever, pus, increased redness, warmth, or rapidly spreading rash.
  • Eczema symptoms do not improve after 1-2 weeks of consistent and appropriate self-care measures.
  • You experience severe pain, significant sleep loss due to itching, or the condition is causing significant psychological distress.

Daily Skincare Tips

  • Bathing: Take short (5-10 minute) lukewarm baths or showers. Avoid hot water, which can further dry the skin. Use mild, fragrance-free cleansers and avoid harsh scrubbing.
  • Moisturizing: Apply a generous amount of emollient immediately after gently patting the skin dry (within 3 minutes) to help seal in moisture. Reapply frequently throughout the day, especially after washing hands.
  • Clothing: Wear loose-fitting clothing made from soft, breathable fabrics like 100% cotton. Avoid wool and synthetic materials that can irritate the skin.
  • Laundry: Use fragrance-free and dye-free laundry detergents and avoid fabric softeners.
  • Sun Protection: Use mineral-based sunscreens containing zinc oxide or titanium dioxide, as chemical sunscreens can sometimes be irritating to sensitive skin. Apply liberally 15-20 minutes before sun exposure.

Prevention and Long-Term Management

  • Humidifiers: Using a humidifier, especially in air-conditioned environments, can help to increase ambient humidity and reduce skin dryness.
  • Trigger Identification and Avoidance: Keep a diary to track potential triggers, such as specific foods, environmental exposures (e.g., sandstorm days), and stress levels, to help identify and avoid personal exacerbating factors.
  • Consistent Skincare Routine: Adhere to a daily skincare regimen that includes regular emollient application, even during periods of remission, to maintain the skin barrier.

Common Myths and Misconceptions

  • Myth: “Eczema is contagious.” Fact: Eczema is a non-contagious condition resulting from a combination of genetic and immune factors and cannot be spread through skin contact.
  • Myth: “Steroid creams are unsafe.” Fact: Topical corticosteroids are safe and effective when used appropriately under the guidance of a healthcare professional. Concerns about side effects are usually associated with prolonged use of high-potency steroids without medical supervision.
  • Myth: “Moisturizers worsen flares.” Fact: Regular use of appropriate emollients is essential for managing eczema, both during flares and in between, to help repair the skin barrier and reduce the frequency and severity of flares.

Conclusion

Effective eczema management requires a comprehensive, proactive approach. This involves identifying and avoiding personal triggers, carefully maintaining the skin barrier with appropriate emollients, seeking timely medical care for flares and complications, and adopting consistent daily skincare habits. By increasing awareness, providing access to tailored treatment strategies, and emphasizing long-term management, people with eczema can experience significant relief and enjoy a better quality of life.

Don’t let eczema take control. Discover how Metabase Cream’s intensive care can help soothe your skin and restore comfort.

Try Metabase today!